We are pleased to announce that Dr. Annalise Rahman-Filipiak, a faculty member in our Leaders Initiative and current junior investigator mentee in our REC program, received a five-year K23 Mentored[…]
Dr. Alexandru D. Iordan, an affiliate of our Center and recent pilot project recipient, was recently awarded an Alzheimer’s Association Research Fellowship (AARF) which supports postdoctoral fellows engaged in Alzheimer’s[…]
More information about our five years of funding from the National Institutes of Health, a new donor gift to support health disparities research in dementia, our registry that offers ongoing[…]
August 23, 2021 Ann Arbor, MI – Federal funding has been confirmed to expand a collaboration between the University of Michigan, Michigan State University and Wayne State University that aims[…]
July 30, 2021 Ann Arbor, MI – The work of affiliates of the Michigan Alzheimer’s Disease Research Center captured the attention of the Journal of Biological Chemistry last week for[…]
In addition to our Center’s main longitudinal research study, the University of Michigan Memory and Aging Project (UM-MAP), we invite anyone interested in participating in aging research studies to join[…]
Note: Aducanumab is not available at Michigan Medicine. In August 2021, the Pharmacy and Therapeutics committee voted against its use based on a review of the available information. What is aducanumab (Aduhelm™)?[…]
June 7, 2021 On June 7th, the United States Food and Drug Administration (FDA) approved Aducanumab as a medication for Alzheimer’s disease. This is the first medication targeting Alzheimer’s disease[…]